Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for ...

随着全球老龄化趋势加剧以及生活方式的改变，肌少症和肥胖的患病率持续攀升。肌少症作为一种与年龄相关的骨骼肌功能下降疾病，逐渐成为影响老年人生活质量的主要威胁。而肥胖不仅与代谢紊乱、心血管疾病等多种慢性病密切相关，还会掩盖肌少症的存在，使患者在日常生活中 ...

在如今的健康话题中，肌少症性肥胖（Sarcopenic Obesity, SO）所引发的关注愈发成为焦点。我们时常把瘦与胖看作截然不同的两类身体状态，却未曾想到，现代医学告诉我们，两者可以奇妙地并存于一个人的身体中，形成复杂且棘手的健康问题。那么，什么是肌少症性肥胖呢？它又为何会成为现代社会中不容忽视的健康危机？

Enobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity undergoing treatment with semaglutide.Topline results from the Phase ...

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on ...

BIO-101 (SARCONEOS) is under development for the treatment of acute respiratory distress syndrome (ARDS) associated with COVID-19 pneumonia and COVID-19 induced respiratory failure, age-related ...

LONDON – Medical experts proposed a radical overhaul of how obesity is diagnosed, moving away from relying on body mass alone and adding broader measurements such as heart health. The ...

She was the classic case of being skinny fat, a person who has normal body weight but has a high percentage of body fat ...

The Lancet medical journal’s Diabetes & Endocrinology Commission last week proposed a new definition and method for diagnosing obesity, beyond simply looking at a person’s Body Mass Index (BMI), the ...

Villareal, a professor at the Baylor College of Medicine in Houston, has told the National Institute of Ageing the “most important component” of training to stall those effects. According to the ...

Scientifically, it’s known as sarcopenic obesity, and it comes with hidden health risks. Being “skinny fat” isn’t about how much you weigh; it’s about your body composition—the ratio ...